An interesting article on the dilemma faced by the approving authorities like Nice. Approving drugs that don't work well takes funds away from those that do work well.
Evidence-vs-access-addressing-the-balance-in-a... - CLL Support
Evidence-vs-access-addressing-the-balance-in-assessing-new-cancer-drugs?
Written by
Myrddin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Getting the balance right: Faster access to new drugs doesn’t always mean better treatment
push to speed new drug assessments:...
Multiple cancer drugs on medicare part d
just a question. Is anybody getting more than one drug for cll at the same time on medicare part...
The High Cost of Cancer Drugs Explained Clearly
time you hear about how the drug companies justify the high cost of drugs, such as Imbruvica, you...
Are there any targeted drugs that only kill cancerous wbc?
I don't understand why it is called a targeted drug if it kills healthy red and white blood cells,
Ordered my Home PCR Test to access new treatments (Sotrovimab and Molnupiravir)
within 5 days of the test to get access to the new drugs\\" (assumed the drugs won't be effective...
New Drug!!
Confused are the dr.s still using chemo with new drugs
What do you have to say about Cancer Drug Costs?
New Vaccine vs Evusheld
